# Which joint care may help you move more easily?

*Clear Choices for Joint Injections Tempe*

> Joint injections Tempe choices explained plainly, from movement and braces to cortisone, gel, PRP made from blood, marrow care, and surgery.

Keep the joint moving at a level that doesn't bring a strong flare. Easy strengthening can help nearby muscles share the load. A brace, cane, cold, or warmth may also make daily tasks easier. If soreness still limits you, ask what each clinic choice can and can't do.

## What can help before a joint procedure?

A tailored exercise plan can build strength without forcing the sore joint. Changing the length or pace of an activity may also reduce strain. Some pain medicines help while you take them, but they don't suit every health history. Ask your doctor before starting or changing medicine.

## What can a cortisone shot do?

A cortisone shot may ease soreness most clearly during the early weeks. It may help you sleep, walk, or take part in exercise. The medical word cartilage means the smooth layer covering each bone end. The shot isn't meant to rebuild that layer or promise lasting relief.

## What should you know about gel shots?

Gel shots place a thick, slippery gel into the joint. The gel is meant to act like the fluid already there. Research hasn't settled how much the gel helps. Ask what result would make the cost and time worthwhile for you.

## What are PRP and marrow choices?

PRP means platelet-rich plasma, a fluid made from your own blood. The blood is spun so platelets gather in less fluid; platelets are tiny blood parts carrying substances used in healing. Marrow care begins with fluid from inside a bone, and clinics prepare both fluids in different ways. That helps explain why study results don't agree; it doesn't tell you to rule either one out.

## When does surgery belong in the discussion?

Surgery may enter the talk when soreness and joint damage greatly limit daily life. It has its own healing time and risks, yet it may fit some joints. Keep doing safe home movement while you compare the likely gains and burdens. QC Kinetix medical providers offer regenerative treatments by collecting blood or bone marrow, making a concentrate, and putting it inside the aching joint.

## Sources

1. The 2015 Cochrane review of 27 trials (1,767 participants) found intra-articular corticosteroid better than sham for knee OA pain (SMD -0.40, 95% CI -0.58 to -0.22; NNTB 8), but the benefit decayed with time: moderate at 1-2 weeks, small at 13 weeks, and no evidence of any effect at 26 weeks. All outcomes were graded LOW quality.
   Jüni P, et al. — [Intra-articular corticosteroid for knee osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/26490760/). *Cochrane Database Syst Rev*, 2015. DOI: 10.1002/14651858.CD005328.pub3.
2. A 2022 BMJ systematic review and meta-analysis of 169 trials (21,163 participants) found viscosupplementation produced only a small pain reduction versus placebo (SMD -0.08, 95% CI -0.15 to -0.02; about -2.0 mm on a 100 mm VAS), below the minimal clinically important difference, and trial sequential analysis indicated conclusive evidence of clinical equivalence with placebo since 2009.
   Pereira TV, et al. — [Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/36333100/). *BMJ*, 2022. DOI: 10.1136/bmj-2022-069722.
3. The RESTORE randomized trial (288 participants, leukocyte-poor PRP, 3 weekly injections) found no significant difference from saline placebo at 12 months in knee pain (-2.1 vs -1.8 points; difference -0.4, 95% CI -0.9 to 0.2) or in medial tibial cartilage volume (-1.4% vs -1.2%), with 29 of 31 secondary outcomes also showing no between-group difference.
   Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415.
4. FDA's HCT/P guidance sets out the minimal-manipulation and homologous-use criteria that decide whether a human cell or tissue product is regulated solely under 21 CFR Part 1271 (section 361) or requires a biologics licence; cell-based orthopaedic injections that fall outside those criteria are unapproved drugs and biological products, and no cell-based product is FDA-approved to treat osteoarthritis.
   U.S. Food and Drug Administration — [Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use - Guidance for Industry and FDA Staff](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal). *U.S. Food and Drug Administration*, 2020.
5. A 2024 network meta-analysis of 48 studies (9,338 knees) at minimum 6-month follow-up ranked PRP first for pain and function (SUCRA 91.5), then BMAC (76.5) and hyaluronic acid (53.1), with corticosteroid (15.2) barely above placebo (13.7) at that time point.
   Jawanda H, et al. — [Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/38331363/). *Arthroscopy*, 2024. DOI: 10.1016/j.arthro.2024.01.037.
6. A systematic review of 105 clinical orthopaedic PRP studies found only 11 (10%) described the preparation protocol well enough to be repeated, and only 17 (16%) reported quantitative metrics on the composition of the final PRP product - so 'PRP' in one trial is frequently not the same product as 'PRP' in another.
   Chahla J, et al. — [A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature.](https://pubmed.ncbi.nlm.nih.gov/29040132/). *J Bone Joint Surg Am*, 2017. DOI: 10.2106/JBJS.16.01374.
7. The 2019 ACR/Arthritis Foundation OA guideline makes a STRONG recommendation for intra-articular glucocorticoid injection in knee OA, alongside strong recommendations for exercise, weight loss, self-management, tai chi, cane use, bracing and NSAIDs; intra-articular steroid injection for HAND OA is only conditionally recommended.
   Kolasinski SL, et al. — [2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.](https://pubmed.ncbi.nlm.nih.gov/31908163/). *Arthritis Rheumatol*, 2020. DOI: 10.1002/art.41142.
8. The AAOS third-edition non-arthroplasty knee OA guideline (2022) issues 29 recommendations across non-pharmacologic and pharmacologic care, and its work group explicitly flagged the need for better research on intra-articular corticosteroid, hyaluronic acid and platelet-rich plasma.
   Brophy RH, et al. — [AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.](https://pubmed.ncbi.nlm.nih.gov/35383651/). *J Am Acad Orthop Surg*, 2022. DOI: 10.5435/JAAOS-D-21-01233.
9. A 2021 JAMA review of hip and knee osteoarthritis places intra-articular steroid injections as providing SHORT-TERM pain relief within a management model whose cornerstones are exercise, weight loss if appropriate and education, complemented by topical or oral NSAIDs, with joint replacement reserved for advanced symptoms and structural damage.
   Katz JN, et al. — [Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review.](https://pubmed.ncbi.nlm.nih.gov/33560326/). *JAMA*, 2021. DOI: 10.1001/jama.2020.22171.
10. A meta-analysis of 14 placebo cohorts (1,076 patients) found intra-articular NORMAL SALINE alone produced statistically and clinically meaningful improvement in VAS pain and WOMAC scores lasting up to 6 months - meaning a large share of the improvement people attribute to an injection is not attributable to the drug in the syringe.
   Saltzman BM, et al. — [The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies.](https://pubmed.ncbi.nlm.nih.gov/28027657/). *Am J Sports Med*, 2017. DOI: 10.1177/0363546516680607.
11. A meta-analysis of 10 RCTs of RECURRENT intra-articular corticosteroid injections (2-8 injections per patient) found they often gave inferior or non-superior relief compared with hyaluronic acid, PRP, saline or orgotein at 3 months and beyond, and no benefit over placebo in pain or function at 12-24 months.
   Donovan RL, et al. — [Effects of recurrent intra-articular corticosteroid injections for osteoarthritis at 3 months and beyond: a systematic review and meta-analysis in comparison to other injectables.](https://pubmed.ncbi.nlm.nih.gov/36108937/). *Osteoarthritis Cartilage*, 2022. DOI: 10.1016/j.joca.2022.07.011.
12. A review of ten studies found single local corticosteroid injections caused a significant but TRANSIENT rise in blood glucose in patients with diabetes, with no adverse reactions or complications reported, and concluded such injections are most likely safe in people whose diabetes is well controlled.
   Waterbrook AL, et al. — [Blood Glucose Levels After Local Musculoskeletal Steroid Injections in Patients With Diabetes Mellitus: A Clinical Review.](https://pubmed.ncbi.nlm.nih.gov/28394710/). *Sports Health*, 2017. DOI: 10.1177/1941738117702585.
13. A meta-analysis found ipsilateral intra-articular corticosteroid injection within 3 months BEFORE joint arthroplasty was associated with increased periprosthetic joint infection risk, and the authors recommend against performing arthroplasty on a joint injected within that window - while injections given at any time overall showed no such association.
   Lai Q, et al. — [Prior Intra-articular Corticosteroid Injection Within 3 Months May Increase the Risk of Deep Infection in Subsequent Joint Arthroplasty: A Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/34919065/). *Clin Orthop Relat Res*, 2022. DOI: 10.1097/CORR.0000000000002055.
14. A clinical review of peripheral joint injections frames them as a treatment for joint-mediated pain (arthritis, tendinopathy, bursitis) that has NOT responded to conservative management, and states plainly that these injections are typically not curative - their objective is to reduce pain enough to allow physical and pharmacologic rehabilitation to work.
   Marcolina A, et al. — [Peripheral Joint Injections.](https://pubmed.ncbi.nlm.nih.gov/35526972/). *Phys Med Rehabil Clin N Am*, 2022. DOI: 10.1016/j.pmr.2022.01.005.

## Would you like to talk with the clinic team?

Bring your medicine list, dates of past joint care, and notes about the soreness. Describe the daily task that soreness has made harder. Ask which care could follow when the first treatment doesn't help.

The nearest location for most Tempe neighborhoods is in Chandler at 1100 S. Dobson Rd., Suite 210. Call (602) 837-PAIN to discuss scheduling. The clinic can explain what happens during the visit.

Talk to the clinic team: <https://joint-pain.qckaz.com/?src=jointinjectionstempe.com>

---

Clear help for a sore joint.

Joint injections Tempe answers: why a joint aches, ways to ease soreness yourself, when care is needed, and clinic choices.

Understand the soreness, the warning signs, and possible care.

This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Chandler location recommended here, and the business may benefit when a reader books.

© 2026 Tempe Joint Field Guide. General health education only; not a diagnosis or personal medical advice.